These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33306112)

  • 1. Multimodality Therapy for Locoregional Nasopharyngeal Carcinoma-A Decision Tool for Treatment Optimization.
    Rosenberg AJ
    JAMA Netw Open; 2020 Dec; 3(12):e2030672. PubMed ID: 33306112
    [No Abstract]   [Full Text] [Related]  

  • 2. The Importance of Locoregional Therapy in Metastatic Nasopharyngeal Cancer.
    Riaz N; Sherman E; Lee N
    JAMA Oncol; 2020 Sep; 6(9):1353-1354. PubMed ID: 32701124
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma.
    Liu H; Ding XR; Song YQ; Jiang C; Zhong XM; Hui HX
    J Biol Regul Homeost Agents; 2020; 34(6):2115-2119. PubMed ID: 33191713
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloid leukemia following the treatment of nasopharyngeal carcinoma.
    Kassar O; Mseddi S; Mdhaffer M; Bellaaj H; Mnif S; Ghorbel M; Sennena H; Elloumi M
    Tunis Med; 2017 Mar; 95(3):222. PubMed ID: 29446820
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer.
    Gairola M; Prabhash K; Babu G; Chaturvedi P; Kuriakose M; Birur P; Anand AK; Kaushal A; Mahajan A; Syiemlieh J; Singhal M; Ramachandra P; Goyal S; John S; Nayyar R; Patil VM; Rao V; Roshan V; Rath GK
    Indian J Cancer; 2020 Feb; 57(Supplement):S9-S11. PubMed ID: 32167065
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
    Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
    Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.
    Zhang Y; Li WF; Liu X; Chen L; Sun R; Sun Y; Liu Q; Ma J
    Radiother Oncol; 2018 Oct; 129(1):18-22. PubMed ID: 29258695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
    BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Fang FM; Huang TL; Lin YH; Chien CY; Chuang HC; Luo SD; Lin HC; Lin YT; Li SH; Liao KC; Tsai WL
    Head Neck; 2019 May; 41(5):1282-1289. PubMed ID: 30548091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nasopharyngeal carcinoma.
    Kraiphibul P; Atichartakarn V
    J Med Assoc Thai; 1992 Aug; 75(8):435-44. PubMed ID: 1300360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
    Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protracted Lhermitte Sign After Cisplatin and Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Gutschenritter T; Matthiesen C; Razaq M
    Am J Ther; 2018; 25(4):e490-e492. PubMed ID: 28296710
    [No Abstract]   [Full Text] [Related]  

  • 14. Current treatment of nasopharyngeal carcinoma.
    Chan AT
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S302-3. PubMed ID: 21943991
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical assessment of the radiotherapy and chemotherapy combined with cetuximabin in the treatment of nasopharyngeal carcinoma].
    Wang XX
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Aug; 30(15):1229-1231. PubMed ID: 29798336
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?
    Lee VH; Lam KO; Chang AT; Lam TC; Chiang CL; So TH; Choi CW; Lee AW
    J Oncol Pract; 2018 Oct; 14(10):594-602. PubMed ID: 30312564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies.
    Tyler MA; Mohamed ASR; Smith JB; Aymard JM; Fuller CD; Phan J; Frank SJ; Ferrarotto R; Kupferman ME; Hanna EY; Gunn GB; Su SY
    Laryngoscope; 2020 Jan; 130(1):86-93. PubMed ID: 30706478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensify the studies on radiotherapy-based combined treatment of nasopharyngeal carcinoma].
    Xu GZ; Tang PZ; Luo JW
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):177-9. PubMed ID: 22805015
    [No Abstract]   [Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis.
    Liao W; Huang J; Wu Q; Zhu G; Wang X; Wen F; Zhang P; Zhang N; Li Q
    Oral Oncol; 2019 Jun; 93():15-20. PubMed ID: 31109691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nasopharyngeal carcinoma in pediatrics].
    Díez B; Silva M; Gallo G
    Bol Med Hosp Infant Mex; 1984 Jun; 41(6):329-34. PubMed ID: 6477695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.